Abstract

Heyam G. Al Mousawi, Raghda Abbas Razaq

The objectives of this study were analysis of the secondary metabolite products and evaluation of Anti-bacterial activity. The FTIR analysis of Penicillium italicum proved the presence of functional group assignment Alkenes, Alkyl halides, Amide, and Alkane with Intensity 819.75 Bending (Strong), 1018.41 Stretch (Strong), 1238.30 Stretch (Strong), 1379.10 Stretch (Strong), 1614.42 Stretch (Bending), 2850.79 Stretch (Strong), 2920.23Stretch (Strong). The FTIR analysis of Fusarium oxysporum proved the presence of functional group assignment Alkenes, Alkyl halides, Amide, Acid and Alkane with Intensity 875.68 Bending (Strong =C–H), 1016.49 Stretch (Strong C-F), 1024.20 Stretch (Strong C-F), 1197.79 Stretch (Strong C-F), 1317.38 Stretch (Bending N-H), 1716.65 Stretch (Strong C=O), 2850.79 Stretch (Strong C-H), 2922.16 Stretch (Strong C-H). Penicillium italicum bioactive compounds and standard antibiotics were (4.66±0.21), (5.77±0.15), (6.02±0.18), (3.63±0.23), and (5.17±0.32) uses Penicillium italicum bioactive compounds, and (2.11±0.12), (1.25±0.13), (2.98±0.12), (2.00±0.12), and (2.04±0.12) uses Rifambin, and (1.01±0.19), (2.93±0.11), (2.40±0.12), (2.00±0.10), and (1.81±0.11) uses Cefotoxime for Staphylococcus aureus, Escherichia coli, Proteus mirabilis, Klebsiella pneumonia, Pseudomonas eurogenosa respectively. Fusarium oxysporum bioactive compounds and standard antibiotics were (3.07±0.24), (5.94±0.36), (4.18±0.29), (5.63±0.28), and (4.09±0.27) uses Fusarium oxysporum bioactive compounds, and (1.09±0.11), (2.89±0.16), (1.59±0.11), (2.25±0.12), and (0.95±0.08) uses Rifambin, and (1.59±0.19), (1.15±0.12), (1.11±0.09), (2.49±0.10), and (0.95±0.07) uses Cefotoxime for Staphylococcus aureus, Escherichia coli, Proteus mirabilis, Klebsiella pneumonia, Pseudomonas eurogenosa respectively.

 

How to Cite this Article

Pubmed Style Heyam G. Al Mousawi, Raghda Abbas Razaq. Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness. SRP. 2021; 12(1): 1493-1500. doi:10.31838/srp.2021.1.210 Web Style Heyam G. Al Mousawi, Raghda Abbas Razaq. Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness. http://www.sysrevpharm.org/?mno=51242 [Access: March 31, 2021]. doi:10.31838/srp.2021.1.210 AMA (American Medical Association) Style Heyam G. Al Mousawi, Raghda Abbas Razaq. Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness. SRP. 2021; 12(1): 1493-1500. doi:10.31838/srp.2021.1.210 Vancouver/ICMJE Style Heyam G. Al Mousawi, Raghda Abbas Razaq. Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness. SRP. (2021), [cited March 31, 2021]; 12(1): 1493-1500. doi:10.31838/srp.2021.1.210 Harvard Style Heyam G. Al Mousawi, Raghda Abbas Razaq (2021) Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness. SRP, 12 (1), 1493-1500. doi:10.31838/srp.2021.1.210 Turabian Style Heyam G. Al Mousawi, Raghda Abbas Razaq. 2021. Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness. Systematic Reviews in Pharmacy, 12 (1), 1493-1500. doi:10.31838/srp.2021.1.210 Chicago Style Heyam G. Al Mousawi, Raghda Abbas Razaq. "Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness." Systematic Reviews in Pharmacy 12 (2021), 1493-1500. doi:10.31838/srp.2021.1.210 MLA (The Modern Language Association) Style Heyam G. Al Mousawi, Raghda Abbas Razaq. "Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness." Systematic Reviews in Pharmacy 12.1 (2021), 1493-1500. Print. doi:10.31838/srp.2021.1.210 APA (American Psychological Association) Style Heyam G. Al Mousawi, Raghda Abbas Razaq (2021) Fermentation extract of Penicillium italicum and Fusarium oxysporum and a statement of its Biological Effectiveness. Systematic Reviews in Pharmacy, 12 (1), 1493-1500. doi:10.31838/srp.2021.1.210